Podcast

Few & Far Between: How Biotech Gets Built

Author: Adam Gottlieb
Feed episode count: 35
Official site: https://biorasi.com/few-far-between-podcast/
RSS: https://feeds.castos.com/kd1o1
JSON: /v1/public/podcasts/few-far-between-how-biotech-gets-built-4067896
Markdown: /podcast/few-far-between-how-biotech-gets-built-4067896.md

Summary

Welcome to Few & Far Between! Melissa Alesse, President of Biorasi, is your host for fascinating conversations - from clinical research and policymakers to biotech innovators and industry leaders.

Episodes

May 12, 2026 · not_requested

Episode 71: Chris O'Brien, Former ⁨Biorasi⁩ CEO and Current CEO of ⁨Rancho Biosciences

Duration seconds: 2604
Source: https://few-far-between-conversations-about-rare-disease-research.castos.com/episodes/x-episode

HTML Markdown JSON

Mar 17, 2026 · not_requested

Episode 69: Zak Kohane, Chair of the Department of Biomedical Informatics at Harvard Medical School

Duration seconds: 3746
Source: https://few-far-between-conversations-about-rare-disease-research.castos.com/episodes/episode-69

HTML Markdown JSON

Jan 27, 2026 · not_requested

Video Episode 68: Sinan Gölhan, CEO at GelTech Labs

Duration seconds: 2656
Source: https://few-far-between-conversations-about-rare-disease-research.castos.com/episodes/sinan

HTML Markdown JSON

Jan 7, 2026 · not_requested

Video Episode 67: Aoife Brennan, President and CEO of Climb Bio

Duration seconds: 4319
Source: https://few-far-between-conversations-about-rare-disease-research.castos.com/episodes/video-episode-67

HTML Markdown JSON

Dec 16, 2025 · not_requested

Episode 66: Mark Abelson, Founder of Ora Clinical

Duration seconds: 2607
Source: https://few-far-between-conversations-about-rare-disease-research.castos.com/episodes/episode-66-mark-abelson-founder-of-ora-clinical

HTML Markdown JSON

Nov 24, 2025 · not_requested

Video Episode 65 - Amit Etkin, Founder and CEO of Alto Neuroscience

Duration seconds: 4011
Source: https://few-far-between-conversations-about-rare-disease-research.castos.com/episodes/episode-65

HTML Markdown JSON

Nov 11, 2025 · not_requested

Video Episode 64 - Professor Justin Stebbing

Duration seconds: 2850
Source: https://few-far-between-conversations-about-rare-disease-research.castos.com/episodes/episode-64-professor-justin-stebbing

HTML Markdown JSON

Oct 28, 2025 · not_requested

Video Episode 63 - Bruce Leuchter, MD, President and CEO of Neurvati Neurosciences

Duration seconds: 3676
Source: https://few-far-between-conversations-about-rare-disease-research.castos.com/episodes/video-episode-63-bruce-leuchter-md-president-and-ceo-of-neurvati-neurosciences

HTML Markdown JSON

Oct 22, 2025 · not_requested

Episode 62: Ken Suzuki, Chief Marketing Officer at Nautilus Biotechnology

Duration seconds: 2655
Source: https://few-far-between-conversations-about-rare-disease-research.castos.com/episodes/episode-62-ken-suzuki-chief-marketing-officer-at-nautilus-biotechnology

HTML Markdown JSON

Oct 1, 2025 · not_requested

Episode 61: Woody Bryan, President and CEO of Revolo Biotherapeutics

Duration seconds: 2718
Source: https://few-far-between-conversations-about-rare-disease-research.castos.com/episodes/episode-61-woody-bryan-president-and-ceo-of-revolo-biotherapeutics

HTML Markdown JSON

Sep 17, 2025 · not_requested

Episode 60: Part Two: Yochi Slonim, Co-Founder and CEO at Anima Biotech

Duration seconds: 2531
Source: https://few-far-between-conversations-about-rare-disease-research.castos.com/episodes/episode-60-part-two-yochi-slonim-co-founder-and-ceo-at-anima-biotech

HTML Markdown JSON

Sep 3, 2025 · not_requested

Episode 59, Part One: Yochi Slonim, Co-Founder and CEO at Anima Biotech

Duration seconds: 2621
Source: https://few-far-between-conversations-about-rare-disease-research.castos.com/episodes/episode-59-part-one-yochi-slonim-co-founder-and-ceo-at-anima-biotech

HTML Markdown JSON

Aug 14, 2025 · not_requested

Episode 58: Jerry McLaughlin, CEO and Board Member at Life Biosciences

Duration seconds: 2683
Source: https://few-far-between-conversations-about-rare-disease-research.castos.com/episodes/episode-58-jerry-mclaughlin-ceo-and-board-member-at-life-biosciences

HTML Markdown JSON

Jul 22, 2025 · not_requested

Episode 57: Jim Brown, DVM, President and CEO of DURECT Corporation

Duration seconds: 2693
Source: https://few-far-between-conversations-about-rare-disease-research.castos.com/episodes/episode-57-jim-brown-dvm-president-and-ceo-of-durmuy

HTML Markdown JSON

Jul 15, 2025 · not_requested

Episode 56, Part Two: Michael Tolentino, MD, Co-Founder and Head Scientific Consultant, Aviceda Therapeutics

Duration seconds: 2368
Source: https://few-far-between-conversations-about-rare-disease-research.castos.com/episodes/episode-56-part-two-michael-tolentino-md-co-foun3dj

HTML Markdown JSON

Jul 9, 2025 · not_requested

Episode 55: Julio G. Martinez-Clark, CEO and Co-Founder at bioaccess®

Duration seconds: 2326
Source: https://few-far-between-conversations-about-rare-disease-research.castos.com/episodes/episode-56-julio-g-martinez-clark-ceo-and-co-founxst

HTML Markdown JSON

May 28, 2025 · not_requested

Episode 54, Part One: Michael Tolentino, MD, Co-Founder and Head Scientific Consultant, Aviceda Therapeutics

Duration seconds: 2711
Source: https://few-far-between-conversations-about-rare-disease-research.castos.com/episodes/episode-54-part-one-michael-tolentino-md-co-founder-and-head-scientific-consultant-aviceda-therapeutics

HTML Markdown JSON

Apr 29, 2025 · not_requested

Episode 53: Frank David, Founder and Managing Director, Pharmagellan

Duration seconds: 3046
Source: https://few-far-between-conversations-about-rare-disease-research.castos.com/episodes/episode-53-frank-david-founder-and-managing-director-pharmagellan

HTML Markdown JSON

Apr 23, 2025 · not_requested

Episode 52: Joshua Kresh, Emily Michiko Morris, and Mark Schultz, IPPI

Duration seconds: 3125
Source: https://few-far-between-conversations-about-rare-disease-research.castos.com/episodes/episode-52-joshua-kresh-emily-michiko-morris-and-mark-schultz-ippi

HTML Markdown JSON

Apr 3, 2025 · not_requested

Episode 51: Dan Oliver, CEO and Founder, Rejuvenate Bio

Duration seconds: 3305
Source: https://few-far-between-conversations-about-rare-disease-research.castos.com/episodes/episode-51-dan-oliver-ceo-and-founder-rejuvenate-bio

HTML Markdown JSON

Mar 18, 2025 · not_requested

Epsiode 50: Jonathan Rigby, Chairman and CEO, Sernova

Duration seconds: 3122
Source: https://few-far-between-conversations-about-rare-disease-research.castos.com/episodes/epsiode-50-jonathan-rigby-chairman-and-ceo-sernova

HTML Markdown JSON

Feb 27, 2025 · not_requested

Episode 49: Eileen Faucher, Principal and Founder, Brass Tacks Health

Duration seconds: 2137
Source: https://few-far-between-conversations-about-rare-disease-research.castos.com/episodes/episode-49-eileen-faucher-principal-and-founder-brass-tacks-health

HTML Markdown JSON

Feb 18, 2025 · not_requested

Episode 48: John Celebi, President and CEO, Sensei Bio

Duration seconds: 2326
Source: https://few-far-between-conversations-about-rare-disease-research.castos.com/episodes/episode-48-john-celebi-president-and-ceo-sensei-bio

HTML Markdown JSON

Jan 15, 2025 · not_requested

Episode 46: Ben Olds and Amy Fenollosa, Haven Human Asset Ventures

Duration seconds: 2609
Source: https://few-far-between-conversations-about-rare-disease-research.castos.com/episodes/episode-46-ben-olds-and-amy-fenollosa-haven-human-asset-ventures

HTML Markdown JSON

Dec 31, 2024 · not_requested

Episode 47 - Marc Lajoie, CEO at Outpace Bio

Duration seconds: 2905
Source: https://few-far-between-conversations-about-rare-disease-research.castos.com/episodes/episode-47-marc-lajoie-ceo-at-outpace-bio

HTML Markdown JSON